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Abstract
Background: Nanoparticles are small-scale substances (<100 nm) with unique properties. Therefore, nanoparticles
pose complex health risk implications. The objective of this study was to detect whether treatment with quercetin
(Qur) and/or arginine (Arg) ameliorated nephrotoxicity induced by two different doses of nano zinc oxide (n-ZnO)
particles.
Method: ZnO nanoparticles were administered orally in two doses (either 600 mg or 1 g/Kg body weight/day for
5 conscutive days) to Wister albino rats. In order to detect the protective effects of the studied antioxidants against
n-ZnO induced nepherotoxicity, different biochemical parameters were investigated. Moreover, histopathological
examination of kidney tissue was performed.
Results: Nano zinc oxide-induced nephrotoxicity was confirmed by the elevation in serum inflammatory markers
including: tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6); and C-reactive protein (CRP). Moreover,
immunoglobulin (IGg), vascular endothelium growth factor (VEGF), and nitric oxide (NO) were significantly increased
in rat serum. Serum urea and creatinine levels were also significantly increased in rats intoxicated with n-ZnO
particles compared with the control group. Additionally, a significant decrease in the non-enzymatic antioxidant
reduced glutathione (GSH) was shown in kidney tissues and serum glucose levels were increased. These
biochemical findings were supported by a histopathological examination of kidney tissues, which showed that in
the animals that received a high dose of n-ZnO, numerous kidney glomeruli underwent atrophy and fragmentation.
Moreover, the renal tubules showed epithelial desquamation, degeneration and necrosis. Some renal tubules
showed casts in their lumina. Severe congestion was also observed in renal interstitium. These effects were dose
dependent. Cotreatment of rats with Qur and/or Arg along with n-ZnO significantly improved most of the deviated
tested parameters.
Conclusions: The data show that Qur has a beneficial effect against n-ZnO oxidative stress and related vascular
complications. Also, its combination with Arg proved to be even more effective in ameliorating nano zinc oxide
nephrotoxicity.
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Background
The rapid growth of the nanotechnology industry has
led to wide-scale production and application of engi-
neered nanoparticles (NPs). NPs are not only used in
industry and medicine but are also increasingly used in
various consumer products such as cosmetics, sunsc-
reens, and food products [1]. However, the properties
that make them useful are also the cause of concern
[2-4]. The ability of NPs to induce toxicity has been
attributed to their increased surface reactivity [5,6].
The small particle size of NPs creates a large surface
area per unit mass and makes them more reactive in a
cell. It has also been proposed that the an increase in
the surface area of NPs greatly increase their ability to
produce reactive oxygen species (ROS) [7,8]. NPs can
enter the human body through different routes such as
inhalation, ingestion and injection [9,10]. They may
then translocate to blood causing adverse biological
reactions in several organs, which are considered to be
the secondary major sites of interaction [11,12]. The
kidney is particularly susceptible to xenobiotics be-
cause of its high blood supply and its ability to concen-
trate toxins. Alteration of the total glutatahione GSH
(tGSH) level in cells can be considered an indication
of adaptive response to cell to oxidative damage.
Nano-ZnO particles at high concentrations signifi-
cantly decreased the renal tGSH level compared with
control values, which indicates functional damage to
kidney tissues.
Considering the hazards of treatment failure, drug re-
sistance and heavy costs associated with current renal
therapy, medicinal plants have attracted the interest of
many researchers in this field. Qur has been found to
protect kidney tissues against age-related NF-κB activity
in the kidneys that leads to increased oxidative stress
[13]. Moreover, Qur protects the kidneys during ische-
mia and reperfusion by preserving higher levels of the
enzyme xanthine dehydrogenase relative to the injurious
enzyme xanthine oxidase [14]. Moreover, it was found
that Qur protected the cells against hydrogen peroxide-
induced oxidative stress and calcium dysregulation that
prevents cell damage [15].
Arginine (Arg) is a nonessential amino acid that has
numerous functions in the body. Arg plays an important
role in cell division, healing of wounds and in immune
function [16-18]. Oral supplementation of L-Arg has
been shown to increase precursors for the synthesis of
nitric oxide (NO) [19], reduce the healing time of injur-
ies, [20], and decrease blood pressure [21]. Dietary inter-
vention with L-Arg resulted in amelioration of a number
of experimental kidney diseases, such as those caused by
subtotal nephrectomy, as well as diabetic nephropathy,
[22]. Nitric oxide (NO) synthesis requires Arg, and plays
a pivotal role in regulating kidney function in patients
with high blood pressure or various renal disorders [23].
Impairment of NO production in these vascular epithe-
lial cells is a characteristic feature of heart failure, and it
can cause harm to the kidneys.
The objective of this study was to assess renal cell
responses to the manufactured NPs to show their poten-
tial toxic biological responses and investigate the reno-
protective effect of Qur and Arg.
Methods
Chemicals
The 50-nm ZnO powder was purchased from Sigma Co.
(USA). All other chemicals used in the study were of
analytical grade, and were from Sigma and Merck.
Animals and treatments
Fifty Wistar albino rats (170–200 g) were used. The
rats were obtained from the Experimental Animal
Care Center, College of Pharmacy, King Saud Univer-
sity. Animals were kept in special cages on a constant
12-h light/12-h dark cycle with air conditioning.
Temperature ranged from 20–22°C with 60% humid-
ity. Rats were fed standard rat pellet chow and had
free access to tap water ad libitum for one week be-
fore the experiment. Animal utilization protocols were
performed in accordance with the guidelines provided
by the Experimental Animal Laboratory and approved
by the Animal Care and Use Committee of King Saud
University, College of Pharmacy. After one week accli-
mation, the rats were kept fasting over night before
treatment and were randomly divided into two classes
according to the dose of ZnO-nanoparticle that was
administered.
Class I consisted of five groups (ten rats per group):
G1: normal healthy animals
G2–G5: animals orally administered 600 mg/kg body
weight/day n-ZnO for 5 days [24], and divided as
follows:
G2:ZnO-intoxicated animals with a low oral dose
(600 mg/kg/day) daily for 5 days.
G3: ZnO-intoxicated animals administered Qur
(200 mg/kg) daily [25].
G4: ZnO-intoxicated animals administered Arg
(200 mg/kg) [26] daily.
G5: ZnO-intoxicated animals co-administered Arg
(200 mg/kg) and Qur (100 mg/kg) daily.
Class II consisted of four groups (G6–G9; ten rats per
group) orally administered 1 g/kg body weight/day for
5 days n-ZnO [25] and divided as follows:
G6: ZnO-intoxicated animals with a high oral dose
(1 g/kg/day) daily for 5 days.
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G7: ZnO-intoxicated animals administered Arg
(200 mg/kg) daily.
G8: ZnO-intoxicated animals administered Qur
(200 mg/kg) daily.
G9: ZnO-intoxicated animals co-administered Arg
(200 mg/kg) and Qur (200 mg/kg) daily.
Qur and/or Arg were orally administered daily for
three weeks from the beginning of the experiment. The
body weights of rats were recorded before and after the
administration period.
At 24 h after the last dose administration, rats were
sacrificed by decapitation, and blood was collected.
Serum was separated by centrifugation at 3000 rpm. for
10 min and kept at −80°C. Both kidneys were harvested
through a midline incision, rinsed in cold isotonic saline,
homogenized, and frozen at −80°C for estimations of
GSH content. Three kidneys from each group were kept
in 10% formalin for histopathological examination.
Serum biochemical analysis
Determination of TNF-α level
The concentration of inflammatory cytokines (TNF-α)
in serum was determined using commercially available
enzyme-linked immunosorbent assay ELISA kits fol-
lowing the instructions supplied by the manufacturer
(DuoSet kits, R&D Systems; Minneapolis, MN, USA).
Determination of CRP level
CRP was measured with latex-enhanced immunonephelo-
metry on a Behring BN II Nephelometer (Dade Behring).
In this assay, polystyrene beads coated with rat mono-
clonal antibodies bind CRP present in the serum sample
and form aggregates. The intensity of scattered light is
proportional to the size of the aggregates and thus con-
centration of CRP present in the sample. The intra-
assay and interassay coefficients of variation for CRP
were 3.3% and 3.2%, respectively. The lower detection
limit of the assay was 0.15 mg/L [27].
Determination of VEGF level
The level of VEGF in serum was determined at 492 nm by
quantitative colorimetric sandwich ELISA (R&D systems,
UK) in accordance with the manufacturer's instructions
[28]. Concentrations were calculated using a standard
curve generated with specific standards provided by the
manufacturer.
Determination of IgG level
The IgG level was measured in serum using a sandwich
ELISA. The capture antibody was goat anti-rat IgG
(Kirkegaard & Perry Laboratories, Inc., Gaithersburg,
MD). Standards were prepared from rat IgG (Sigma
Chemical Co., St. Louis, MO). Goat anti-rat IgG peroxidase
conjugates were diluted 1:250 in PBS/BSA (from Kirkegaard
& Perry Laboratories, Inc.) and used as detecting anti-
bodies. The chromogenic substrate used was 2,2′-azino-di
[3-ethyl-benzthiazoline sulfonate] (ABTS; Kirkegaard &
Perry Laboratories, Inc.). Color development was detected
via optical density at 405 nm using an automated ELISA
plate reader (Bio-tek Instruments, Inc., Winooski, VT) and
immunoglobulin concentrations were determined by com-
parison of sample color development to standard curves
(Kineticalc, Bio-tek Instruments, Inc.).
Determination of IL-6 level
The IL-6 levels were measured by ultra-sensitive ELISA
(Quantikine HS Human IL-6 Immunoassay; R&D Sys-
tems, Minneapolis, MN) with an analytical CV of 6.3%
and a detection level of 0.04 pg/mL [29].
Determination of total nitrite/nitrate level
Serum total nitrite/nitrate level concentration (as an in-
direct measurement of NO synthesis) was assayed using
Griess reagent (sulfanilamide and N-1-naphthylethylene-
diamine dihydrochloride) in acidic medium [30].
Determination of glucose level
Glucose level was estimated using the method of Trin-
der 1969[31].
Determination of serum urea, creatinine and uric acid level
Serum samples were assayed for urea, creatinine, and
uric acid by using standard diagnostic kits.
Determination of renal reduced glutathione (GSH) level
Kidney tissue levels of acid-soluble thiols and reduced
GSH were determined calorimetrically at 412 nm [32].
Homogenates were precipitated with trichloroacetic acid,
and after centrifugation, supernatants were used for the
estimation of protein thiols (Protein-SH) expressed as
μmol/mg wet tissue.
Histopathological techniques
Samples of kidney tissues were collected, and were
fixed in a 4% formaldehyde solution for 24 h. They
were dehydrated in ascending grades of ethyl alcohol,
cleared in xylene, and embedded in paraffin. Paraffin
blocks were cut at 4-μm thickness, then fixed on
glass slides. Sections were stained with hematoxylin
and eosin (H&E) by the following method: they were
hydrated using washes with descending grades of
alcohol, then hematoxylin was added to stain the
nuclei, and afterwards eosin was added to the cyto-
plasm. Another set of unstained slides were stained
with Masson’s trichrome after de-waxing and rehy-
dration of unstained slides. Sections were immersed
in Weigert's working hematoxylin for 10 min then
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washed with water for 5 min, and was rinsed in dis-
tilled water. They were then stained with Biebrich
scarlet for 5 min followed by rinsing in distilled
water. Slides were immersed in phosphotungstic/
phosphomolybdic acid for 10 min. The solution was
discarded. After that sections were transferred dir-
ectly into Light Green for 5 min followed by rinsing
in distilled water. The sections were immersed in
10.1% acetic acid solution for 1 min to visualize de-
position of collagen fibers. This usually makes the
sample turn green [33]. The histological changes
were estimated semi-quantitatively, as being mild,
moderate, or marked by microscopic examination of
histological sections.
Statistical analysis
Data are presented as mean± S.D. Statistical analysis was
performed using an Instat-3 computer program (Graph
pad software Inc, San Diego, CA). One way analysis of
variance (ANOVA) followed by Bonferroni multiple tests
was used to determine the differences between means of
different groups. The level of significance was set at
p≤ 0.05.
Results
The current investigation revealed that the administra-
tion of n-ZnO particles, either in low or high doses,
significantly elevated (p< 0.001) serum inflammatory
markers (TNF- α, CRP, and IL-6) levels compared with
normal control values (Table 1 & 2). Moreover, n-ZnO
treatment significantly increased (p< 0.001) serum IgG,
VEGF, and glucose levels. n-ZnO treatment also increased
total nitrite concentration (Figure 1 and Figure 2), with a
concomitant decrease in renal GSH content compared
with normal control values (p< 0.001) (Figure 3 and
Figure 4). After estimation of renal function para-
meters (serum urea, creatinine and uric acid), there
were no significant changes in the serum levels of
n-ZnO-intoxicated rats as compared with normal con-
trol group (p< 0.05), with the exception of urea and
creatinine levels (Table 3 and 4). Generally, the large
dose of n-ZnO induced significant alteration in the
previous parameters than that of the low dose. Oral ad-
ministration of Qur, Arg or a combination of both sig-
nificantly reduced (p< 0.001) serum TNF-α, CRP, IL-6
compared with n-ZnO-intoxicated rats (Table 1 & 2).
Interestingly, CRP level decreased significantly with
Arg treatment. However, the combination of the two
agents showed a more powerful effect in alleviating the
rise of inflammatory mediator levels. Additionally,
serum IgG, VEGF, nitric oxide, and glucose levels
decreased significantly (p< 0.001), with a concomitant
increase in renal GSH content (p< 0.001) (Figure 1–4).
Arg alone, or in combination with Qur, significantly
decreased serum creatinine level as compared with rats
intoxicated with high dose of n-ZnO particles (p< 0.05)
(Table 4 and). There was no significant change either in
body weight, kidney weight, or in kidney/body weight %
between all the groups (Tables 5 and 6).
The results of these biochemical markers were sup-
ported by the histopathological examination of kidney
tissues stained with HE. This examination revealed that
the animals which received a low dose of n-ZnO showed
moderate atrophy and fragmentation of many glomeruli
compared with control group (Figure 5A). Few renal
tubules showed epithelial desquamation, degeneration
and necrosis and tubular casts in their lumina. Vascular
congestion was also observed in renal interstitium
(Figure 5B), but was less than that observed in intoxi-
cated animals with a high dose of n-ZnO. Quercetin
treatment showed minimum protective effects on the
renal tissues of intoxicated rats (Figure 5C). However, n-
Table 1 Effect of Qur and/or Arg treatment on serum inflammatory markers level in intoxicated rats with a low dose of
n-ZnO particles
Parameters Control n-ZnO Qur Arg Qur+Arg
TNF- α (pg/ml) 242.7 ± 6.1 361.6 ± 9.2a 299.5 ± 3.1*b # # 276.12 ± 4.05*b 300.6 ± 4.1*b # #
CRP (ng/ml) 3.16 ± 0.1 4.4 ± 0.20 a 3.4 ± 0.04*c 3.3 ± 0.04*c 3.1 ± 0.7* # #
IL-6 (pg/ml) 31 ± 2.098 44.33 ± 1.2a 42.86 ± 0.49 a# 35.3 ± .81 a* 35.66 ± 1.21 a*
Data are presented as mean ± S.D. from 10 rats, a P≤ 0.001, b P≤ 0.01, c P≤ 0.05 compared with the normal group, * P≤ 0.001 compared with the n-ZnO-intoxicated
group, # P≤ 0.001, ## P≤ 0.01 compared with the combination group, respectively, using ANOVA followed by Bonferroni as a post-ANOVA test.
Table 2 Effect of Qur and/or Arg treatment on serum inflammatory marker levels in intoxicated rats with a high dose
of n-ZnO particles
Parameters Control n-ZnO Qur Arg Qur+Arg
TNF- α (Pg/ml) 242.7 ± 6.1 371.7 ± 6.1a 293.6 ± 4.3*b 322.18 ± 1.9*b# 314.1 ± 2.9*b#
CRP (ng/ml) 3.16 ± 0.1 4.6 ± 0.11 a 2.9 ± 0.05* 3.0 ± 0.07* 3.7 ± 0.055*b# #
IL-6 (ng/ml) 31 ± 2.098 49.57 ± 1.01 a 39.41 ± 0.62a* 41.80 ± 0.28a*# 44.94 ± 1.02a*###
Data are presented as mean ± S.D. for 10 rats, a P≤ 0.001, b P≤ 0.01 compared with the normal group, * P≤ 0.001 compared with the n-ZnO intoxicated-group, #
P≤ 0.05, ## P≤ 0.01, ### P≤ 0.01 compared with the combination group, respectively, using ANOVA followed by Bonferroni as a post-ANOVA test.
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ZnO intoxicated animals treated with Arg showed a
major improvement in the histopathological destruction
observed in kidney tissues. This was shown by minimal
glomerular shrinkage and lower rates of tubular epithe-
lial desquamation and degeneration (Figure 5D). Intoxi-
cated animals co-treated with quercetin and Arg showed
mild histological changes, in a form of mild glomerular
fragmentation and epithelial exfoliation in few renal
tubules (Figure 5E).
The kidneys of rats treated with a high dose of n-ZnO
showed massive atrophy and fragmentation of numerous
glomeruli. The renal tubules also showed epithelial
desquamation, degeneration and necrosis. Numerous
renal tubules showed casts in their lumina. In addition,
sever congestion was observed in the renal interstitium
(Figure 6B). However, the animals which received
n-ZnO and quercetin showed histopathological changes
in the kidney similar to those detected in the untreated
group (Figure 6C). The animals that received n-ZnO and
Arg showed histopathological changes in the kidney
similar to those detected in the control group (Fig-
ure 6D). However, animals that received n-ZnO, quer-
cetin and arginine showed mild histological changes,
with fragmentation of few glomeruli and epithelial ex-
foliation in few renal tubules (Figure 6E).
Kidney tissues of animals intoxicated with n-ZnO and
stained with Masson’s trichrome showed moderate
(with low dose-intoxicated rats) to marked (with high
dose-intoxicated rats) increase of collagen fiber deposits
in the interstitial tissue (Figure 7B and Figure 8B,
respectively) compared with the normal control group
(Figure 7A and Figure 8A). Animals that received n-ZnO
and quercetin showed a moderate increase of interstitial
collagen deposition (Figure 7C and Figure 8C). How-
ever, Arg-treated groups showed minimum collagen de-
position similar to the control group (Figsure 7D and
8D). Qur- and Arg-treated groups showed a mild in-
crease in collagen deposition (Figure 7E and Figure 8E).
Discussion
Nanoparticles were found to reach the systemic circula-
tion and disseminate to several organs such as the liver,
spleen and kidneys [3,34]. Kidneys play an important
role in eliminating xenobiotics from the body and NPs
absorbed in the systemic circulation can be excreted by
renal clearance [35,36]. Few studies have described the
Figure 1 Effect of Qur and/or Arg treatment on serum IgG (a), VEGF (b), total nitrate/nitrite (c), and glucose (d) concentrations in
intoxicated rats with low dose of n-ZnO particles. Values are expressed as mean± S.D. a P< 0.001, b P< 0.01 compared with the normal
control group, ***P< 0.001 compared with the n-ZnO-intoxicated group, $$P≤ 0.01, $ P≤ 0.05 compared with the Qur-treated group, πππP≤ 0.001,
ππ P≤ 0.01 compared with the combination group, respectively, using ANOVA followed by Bonferroni as a post-ANOVA test.
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potential toxicity of NPs to renal tubular and glomerular
targets [7,37]. Kidney damage with morphological,
pathological, and cellular changes leading to kidney dys-
function after exposure to NPs has been studied [12,38].
In the present study, low and high doses of ZnO NPs
significantly elevated inflammatory cytokine levels, in-
cluding TNF α-, IL-6, and CRP in rat serum compared
with the normal control group. Levels of VEGF, NO and
IgG were also significantly elevated. These findings were
accompanied with a dose dependent increase in serum
urea and creatinine levels in n-ZnO intoxicated rats
compared with normal control rats. Tosu et al. [39]. elu-
cidated the inflammatory effects of 50- and 100-nm
ZnO particles on human umbilical vein endothelial cells
(HUVECs). Nano-ZnO concentrations of ≤ 3 μg/ml
resulted in increased cell proliferation, while those of
≤ 45 μg/ml caused dose-dependent increases in oxidized
glutathione levels. Nano-ZnO particles induced a dose-
dependent increase in the expression of the intercellular
adhesion molecule (ICAM-1) protein, an indicator of vas-
cular endothelium inflammation, and caused marked
increases in NF-κB activity. Additionally, TNF-α, a typical
inflammatory cytokine, induced ICAM-1 expression in
an NF-κB-dependent manner. ZnO also synergistically
Figure 2 Effect of Qur and/or Arg treatment on serum IgG (a),
VEGF (b), total nitrate/nitrite (c), and glucose (d) concentrations
in intoxicated rats with a high dose of n-ZnO particles. Values
are expressed as mean± S.D. a P< 0.001 b P< 0.01 compared with
the normal control group, ***P< 0.001 compared with the n-ZnO-
intoxicated group, $ P≤ 0.01 compared with the arginine-treated
group, $ P≤ 0.05 compared with the Qur-treated group, πππP≤ 0.001,
ππ P≤ 0.01 compared with the combination group, respectively,
using ANOVA followed by Bonferroni as a post-ANOVA test.
Figure 3 Effect of Qur and/or Arg treatment on renal glutathione level in intoxicated rats with a low dose of n-ZnO particles. Values are
expressed as mean± S.D. aP< 0.001 compared with the normal control group, ***P< 0.001 compared with the n-ZnO-intoxicated group,
πππP≤ 0.001, ππ P≤ 0.01 compared with the combination group, using ANOVA followed by Bonferroni as a post-ANOVA test.
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enhanced TNF-α-induced ICAM-1 expression. More-
over, Fine et al. [40] found that exposures to low con-
centrations of zinc oxide elevated circulating levels of
different cytokines, which could account for the symp-
toms of the metal fume fever syndrome. This is in
accordance with the present study as low and high
doses of ZnO NPs significantly elevated cytokines
(TNF-α and IL-6) levels in rat serum compared with
normal control group.
Growing evidence indicates the beneficial role of a
nutrient mixture of L-Arg and Qur in inhibiting
the inflammatory response by down-regulating pro-
inflammatory cytokine protein expression levels [41].
Moreover, Mostafavi et al. [42] found that Qur and Arg
plays a protective role against the imbalance elicited
between the production of free radicals and antioxi-
dant defense systems, and suggested that a combin-
ation of these two antioxidants may find clinical
application where cellular damage is a consequence of
reactive oxygen species.
The current study shows that cytokine (TNF-α and
IL-6) levels were reduced post-Qur treatment compared
with the n-ZnO treated group. This was in accordance
with the results of Behling et al. [43] who found that cis-
platin-treated rats presented a transitory increase in
plasma creatinine levels, tubular cell necrosis and
increased immunostaining for vimentin, alpha-SM-actin,
fibronectin, and NF-κB in the renal cortex and outer me-
dulla. Meanwhile, Qur treatment attenuated renal func-
tional, histological and immunohistochemical alterations
induced by cisplatin [43]. Other studies showed that
NF-κB plays a pivotal role in progressive kidney dis-
eases by regulating the accumulation of macrophages
[44]. Qur potently inhibited NF-κB activation in cul-
tured rat proximal tubular cells (PTCs), because NF-κB
regulates inflammatory signaling and adhesion molecules
in PTCs. Additionally, Qur is known to modulate the ac-
tion of several inflammatory cytokines that are of par-
ticular concern to transplant recipients, including IL-1β,
IL-2, IL-6, IL-15 and TNF-α [45-47]. Hushmendy et al.
[48] found that Qur significantly inhibited cytokine levels
and T-cell proliferation, suggesting that it may be effect-
ive in reducing transplant rejection. These findings may
explain earlier findings that administration of Qur inhib-
ited tubular injury and the elevation in inflammatory
cytokine levels.
In the present study Arg significantly reduced the ele-
vated levels of inflammatory cytokines (TNF-α and IL-6)
Figure 4 Effect of Qur and/or Arg treatment on renal
glutathione level in intoxicated rats with a high dose of n-ZnO
particles. Values are expressed as mean± S.D. aP< 0.001, cP< 0.05
compared with the normal control group, ***P< 0.001 compared
with the n-ZnO-intoxicated group, respectively, using ANOVA
followed by Bonferroni as a post-ANOVA test.
Table 3 Effect of Qur and/or Arg treatment on serum creatinine, urea, and uric acid levels in intoxicated rats with a
low dose of n-ZnO particles
Parameters Control n-ZnO Qur Arg Qur+Arg
Creatinine (mg/dl) 0.4 ± 0.075 0.53 ± 0.077 0.47 ± 0.078 0.44 ± 0.027 0.42 ± 0.069
Urea (mg/dl) 21.4 ± 4.88 32.3 ± 6.83 a 28.6 ± 5.47 27.9 ± 2.92 27.2 ± 4.21
Uric acid (mg/dl) 2.1 ± 0.55 2.51 ± 0.58 2.44 ± 0.78 2.23 ± 0.21 2.06 ± 0.54
Data are presented as mean ± S.D. for 10 rats, a P≤ 0.05 compared with normal group using ANOVA followed by Bonferroni as a post-ANOVA test.
Table 4 Effect of Qur and/or Arg treatment on serum creatinine, urea, and uric acid levels in intoxicated rats with a
high dose of n-ZnO particles
Parameters Control n-ZnO Qur Arg Qur +Arg
Creatinine (mg/dl) 0.4 ± 0.075 0.63 ± 0.087 a 0.51 ± 0.066 0.50 ± 0.033 * 0.50 ± 0.045*
Urea (mg/dl) 21.4 ± 4.88 35.2 ± 5.88 b 29.8 ± 4.57 28.8 ± 2.02 28.2 ± 5.21
Uric acid (mg/dl) 2.1 ± 0.55 3.02 ± 0.53 2.84 ± 0.98 2.93 ± 0.61 2.36 ± 0.55
Data are presented as mean ± S.D. from 10 rats, a P≤ 0.001, b P≤ 0.01 compared with the normal group, * P≤ 0.05 compared with the n-ZnO-intoxicated group,
respectively, using ANOVA followed by Bonferroni as a post-ANOVA test.
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Table 5 Effect of Qur and/or Arg treatment on body weight, kidney weight, and kidney/body weight % in intoxicated
rats with a low dose of n-ZnO particles
Body Weight (g)Initial Final Kidney Weight (g) Kidney/Body Weigh %
Control 251.6 ± 9.39 271.6 ± 23.73 1.22 ± 0.164 0.454± 0.090
n-ZnO 250.4 ± 14.15 280.6 ± 6.50 1.14 ± 0.114 0.405± 0.034
Qur 242.4 ± 14.84 271 ± 19.30 1.3 ± 0.282 0.482± 0.098
Arg 238.2 ± 12.27 262.8 ± 19.66 1.22 ± 0.083 0.528± 0.074
Qur+Arg 235.6 ± 11.19 264.2 ± 17.41 1.18 ± 0.192 0.484± 0.081
Table 6 Effect of Qur and/or Arg treatment on body weight, kidney weight, and kidney/body weight % in intoxicated
rats with a high dose of n-ZnO particles
Body Weight (g) Initial Final Kidney Weight (g) Kidney/Body Weigh %
Control 251.6 ± 9.39 271.6 ± 23.73 1.22 ± 0.164 0.454± 0.090
n-ZnO 232.4 ± 14.87 262.6 ± 22.94 0.94 ± 0.209 0.358± 0.051
Qur 249.4 ± 22.39 272.8 ± 37.79 1.34 ± 0.243 0.496± 0.094
Arg 242 ± 19.583 268.6 ± 19.57 1.12 ± 0.211 0.418± 0.031
Qur+Arg 232 ± 28.87 265± 41.085 1.24 ± 0.201 0.492± 0.076
Figure 5 Photomicrographs of kidney sections stained with hematoxylin and eosin (scale bars = 50 μm), showing: (A) control group,
normal architecture of renal corpuscles with their glomeruli (arrow) and renal tubules (asterisk); (B) intoxicated group with 600 mg/kg
body weight/day n-ZnO particles for 5 days, shrinkage and fragmentation of many glomeruli (arrows) with many renal tubules
showing degeneration, necrosis (arrowhead) and exfoliation of their lining epithelium (curved arrow); (C) Qur-treated group, shrinkage
and fragmentation in many glomeruli (arrow) with necrosis (arrowhead) and exfoliation of lining epithelial cells of many renal tubules
(curved arrow); (D) Arg-treated group, normal architecture of renal corpuscles with their glomeruli (arrow) as well as normal renal
tubules (asterisk); and (E) Qur +Arg-treated group, few glomeruli with shrinkage and fragmentation, and few renal tubules with
epithelial cell exfoliation (curved arrows).
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compared with n-ZnO treated group. Moreover, Arg
alone or in combination with Qur significantly decreased
serum creatinine level as compared with rats intoxicated
with a high dose of n-ZnO particles. This was attributed
to the fact that Arg has various metabolic and immuno-
logic effects and has been considered to be conditionally
essential, particularly under inflammatory and oxidative
stress [49]. It has protective effects against oxidative
stress and inflammation in different pathological condi-
tions [42]. It can modulate the inflammatory response
by modulating the production of inflammatory media-
tors, such as C-reactive protein as well as cytokine re-
lease from activated immune competent cells which play
a crucial role in the progression of the pathology [50].
Elevation of CRP level post_n-ZnO administration
compared with the normal control group in the current
work was in accordance with the work of Kim et al.
[27], who clarify that CRP is related to the incidence of
many pathological condition as coronary heart disease,
hypertension, and inflammation. Both Qur and/or Arg
treatments reduced CRP level compared with n-ZnO
intoxicated group. This is in agreement with Kleemann
et al. [51] who clarified that dietary intake of flavonoids
such as Qur was associated with lower CRP levels.
Moreover, Wu et al. [50] found that Arg can modulate
inflammatory response by modulating the production of
inflammatory mediators, such as C-reactive protein.
The increase in the circulating IgG in rat serum
intoxicated with both doses of ZnO-NPs is an immune
response induced by NPs toxicity. It is suggested that
the increase in the circulating antibodies are the result
of the production of different inflammatory cytokines,
including TNF-α, with potential impact on immuno-
globulin production during inflammation. These results
may indicate tha tZnO-NPs induced inflammatory kid-
ney injury through production of the inflammatory
Figure 6 Photomicrographs of kidney sections stained with hematoxylin and eosin (scale bars = 50 μm), showing: (A) control group,
normal renal corpuscles with normal glomeruli (arrow) and renal tubules (asterisks); (B) intoxicated group with 1 g/kg body weight/
day for 5 days with n-ZnO particles, shrinkage and fragmentation of many glomeruli (arrows). In addition many renal tubules show
degeneration, necrosis (arrowheads) and exfoliation of their lining epithelium (curved arrow). (C) Qur-treated group, many glomeruli reveal
shrinkage and fragmentation (arrows) with degeneration, necrosis (arrowheads) and exfoliation of epithelial lining cells of the renal tubules
(curved arrow). (D) Arg-treated group: Almost all the renal corpuscles with their glomeruli (arrows) as well as the renal tubules (asterisks) are
similar to normal architecture. (E) Qur + Arg-treated group, there were few renal tubules with degeneration, necrosis (arrowhead) and exfoliation
of their lining epithelial cells (curved arrow).
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mediators [52]. The IgG level was reduced by Arg and
Qur treatments. This may explain the role of these
agents to suppress the release of inflammatory
mediators.
There was a significant increase in serum nitrite/ni-
trate level in n-ZnO intoxicated rats. High amounts of
NO are released from the inducible NO synthase (iNOS)
isoform in response to inflammatory stimuli from a var-
iety of cell types [53,54]. Renal proximal tubule and
inner medullary collecting duct cells can produce NO
via expression of an inducible isoform of nitric oxide
synthase [55]. Mesangial cells and invading immune cells
are capable of expressing iNOS upon stimulation with
TNF-α and IL-1b. The release of large amounts of NO
in the glomerulus may lead to the progression of renal
failure during several forms of glomerulonephritis [56].
Increased tissue factor expression is thought to play a
significant role in the development of multiorgan system
failure in acute injury [57]. Vascular endothelial growth
factor (VEGF), which is a potent mitogen for endothelial
cells, has been reported to be expressed in several
tissues, including the kidney. The expression of various
tissue factors, cytokines, and chemokines in response to
inflammatory tissue injury stimulates VEGF synthesizing
cells such as platelets, immune cells, and inflammatory
cells [58-60]. Besides its mitogenic properties, VEGF is
able to promote angiogenesis and increase vascular leak-
age [61,62]. However, it was found that stimulation of
angiogenesis may contribute to the transition from acute
to chronic inflammation. Some investigations have
revealed that new vessels can significantly contribute to
perpetuation of the inflammatory response by expressing
chemokines and adhesion molecules promoting the re-
cruitment of inflammatory cells [63]. This suggests the
possibility that TNF-α and VEGF might act synergistic-
ally to potentiate kidney injury and/or systemic organ
dysfunction [64], and explain the elevation in TNF-α,
NO, and VEGF levels post-n-ZnO treatment compared
with the control group.
The use of anti-angiogenic agents may then represent
an attractive alternative therapeutic tool to prevent or
significantly reduce fibrosis progression .The protective
Figure 7 Photomicrographs of kidney sections from normal and intoxicated rats with 600 mg/kg body weight/day n-ZnO particles for
5 days stained with Masson trichrome (scale bars = 50 μm). All groups revealed normal distribution of a small amount of collagen fibers
(arrow) between the renal tubules in the interstitium.
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ingestion of the agents used alone or in combination,
markedly reduced the dramatic increase in this angio-
genic biomarker in sera of n-ZnO intoxicated rats, sug-
gesting their anti-angiogenic beneficial action. Previous
investigations revealed the role of Arg in reducing VEGF
expression [65].
Serum nitrite/nitrate was significantly decreased upon
treatment of intoxicated animals with Qur or with the
Qur and Arg combination but not with Arg alone. How-
ever, the increase in NO level in the Arg-treated group
was accompanied by a significant increase in renal GSH
content of n-ZnO intoxicated rats. The n-ZnO treated
group showed a significant increase in free radical gener-
ation after n-ZnO treatment with resultant damaging effect
on the kidney tissue as evidenced from histopathological
examination (Figure 5–8). Data of Arg-treated group sug-
gests that pharmacological increases in NO levels did not
exacerbate the increase in free radical formation. High
levels of NO or Arg in the Arg-treated group may be pro-
tective, probably due to their property of scavenging free
radicals as well as inhibiting xanthenes oxidase (XO) en-
zyme [66].
In the present study, GSH levels were significantly
reduced after n-ZnO treatment, while treatment with
both Arg and Qur increased renal GSH content when
compared with the n-ZnO treated group. This was
attributed to the antioxidant properties of both agents.
The Qur antioxidant effect is based on its ability to
quench hydrogen peroxide [14]. Qur reduces platelet ag-
gregation and adhesion by reducing hydrogen peroxide
production [14]. Qur attenuated cyclosporine-induced
oxidative stress by restoring the activity of the antioxida-
tive enzymes glutathione peroxidase and catalase, pre-
venting its nephrotoxic action and kidney damage [67].
Arg significantly reduced lipid peroxidation and increased
GSH content in the heart tissue of exhaustively exercised
rats [68]. These findings augment the current results in
which the combination of both agents significantly
decreased kidney damage by synergistically increasing cel-
lular levels of GSH.
Figure 8 Photomicrographs of kidney sections stained with Masson trichrome (scale bars = 50 μm), showing the Control group (A)
with normal distribution of a small amount of collagen fibers (arrow) between the renal tubules. (B) Intoxicated group with 1 g/kg body
weight/day for 5 days with n-ZnO particles. There was an evident increase of deposition of collagen fibers in the interstitium (arrow). (C) Qur-
treated group, an obvious increase of collagen fibers between the renal tubules (arrow). (D) Arg-treated group, there was a small amount of
collagen fibers between the renal tubules (arrow). (E) Qur +Arg-treated group: Mild increase in collagen fibers between the renal tubules (arrow).
Faddah et al. BMC Complementary and Alternative Medicine 2012, 12:60 Page 11 of 14
http://www.biomedcentral.com/1472-6882/12/60
These biochemical findings were supported by the
histopathological examination of kidney tissues, which
clarified that animals received either low or high doses
of n-ZnO particles showed moderate to massive atrophy
and fragmentation of numerous glomeruli. The renal
tubules showed epithelial desquamation, degeneration
and necrosis. Some renal tubules showed casts in their
lumina. Sever congestion was also observed in renal
interstitium. These hazardous effects were dose-
dependent. Co-treatment of n-ZnO_intoxicated rats with
Qur or Arg, significantly improved most of the deviated
histopathological parameters. The combination of Qur
and Arg nearly prevented the damaging effect of n-ZnO
intoxication that was manifested microscopically by ex-
tensive improvements in the histological features of kid-
ney cells in the form of fragmentation of few glomeruli
and epithelial exfoliation in few renal tubules as well as
marked reduction in deposition of collagen fibers in the
interstitial tissues.
Conclusion
In this study, the ability of ZnO-NPs to exert different
cytotoxic effects was demonstrated. This was evidenced
from the elevation in inflammatory cytokines (TNF, IL6,
and CRP), IgG, VEGF, creatinine levels, as well as NO
induction. These altered parameters contribute to
nephrotoxic potential of n-ZnO particles which was
clear from the histopathological examination. Treatment
with either Arg, Qur, or their combination successively
alleviated the alterations in the previous biomarkers, as
well as effectively reducing the histopathological changes
in n-ZnO cytotoxic rats. This may be related to their
ability to attenuate the extent of liberation of ROS and
inflammatory cytokines induced by such nanoparticles.
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